Edgewise Therapeutics Inc. Common Stock vs INNIO N.V. Ordinary Shares — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while INNIO N.V. Ordinary Shares trades at $16.44 (market cap $13.73B). The key difference: INNIO N.V. Ordinary Shares is far larger — about 3.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and INNIO N.V. Ordinary Shares for 0 Days on average.
| EWTX | INIO | |
|---|---|---|
Market Cap | $3.94B | $13.73B |
Volume | 810,104 | 5,012,195 |
Sector | Health | Industrials |
52-Week High | $48.35 | $41.13 |
52-Week Low | $14.89 | $16.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $15.39B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →